MTHFR and the risk for cerebral venous thrombosis- a meta-analysis

Thrombosis Research

Volumn 125, Issue 4, 2010, Pages

  Gouveia, Liliana O ^a   Canhão, Patrícia ^a  

^a HOSPITAL DE SANTA MARIA   (Portugal)

Author keywords

cerebral venous thrombosis; dural sinus thrombosis; MTHFR C677T; MTHFR mutation; thrombophilia

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2);

ARTICLE; CASE CONTROL STUDY; DNA POLYMORPHISM; GENETIC RISK; HUMAN; KNOWLEDGE BASE; OCCLUSIVE CEREBROVASCULAR DISEASE; PRIORITY JOURNAL; RISK ASSESSMENT; SYSTEMATIC REVIEW; VEIN THROMBOSIS;

ADULT; CASE-CONTROL STUDIES; CONFIDENCE INTERVALS; DATABASES, FACTUAL; FEMALE; GENOTYPE; HUMANS; INTRACRANIAL THROMBOSIS; MALE; METHYLENETETRAHYDROFOLATE REDUCTASE (NADPH2); POLYMORPHISM, GENETIC; RISK; RISK FACTORS; UNITED STATES; VEINS; VENOUS THROMBOSIS;

EID: 77949567138     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2009.10.019     Document Type: Article

References (30)

1. Stam J. Thrombosis of the cerebral veins and sinuses. N Engl J Med 352 (2005) 1791-1798
2. Bousser M.G., and Ferro J.M. Cerebral venous thrombosis: an update. Lancet Neurol 6 (2007) 162-170
3. Ferro J.M., Canhão P., Stam J., and Bousser M.G. Barinagarrementeria and the ISCVT Investigators. Prognosis of cerebral vein and dural sinus thrombosis: results of the International Study on Cerebral Vein and Dural Sinus Thrombosis (ISCVT). Stroke 35 (2004) 664-670
4. Ludermann P., Nabavi D.G., Junker R., Wolff E., Papke K., Buchner H., et al. Factor V Leiden mutation is a risk factor for cerebral venous thrombosis: a case control study of 55 patients. Stroke 29 (1998) 2507-2510
5. Reuner K.H., Ruf A., Grau A., Rickmann H., Stolz E., Jutter E., et al. Prothrombin gene G20210→A transition is a risk factor for cerebral venous thrombosis. Stroke 29 (1998) 1765-1769
6. Zuber M., Toulon P., Marnet L., and Mas J.L. Factor V Leiden mutation in cerebral venous thrombosis. Stroke 27 10 (Oct 1996) 1721-1723
7. Dentali F., Crowther M., and Ageno W. Thrombophilic abnormalities, oral contraceptives, and risk of cerebral vein thrombosis: a meta-analysis. Blood 107 (2006) 2766-2773
8. Wald D.S., Law M., and Morris J.K. Homocysteine and cardiovascular disease: evidence on causality from a meta-analysis. Br Med J 325 (2002) 1202-1206
9. Ray J.G. Meta-analysis of hyperhomocysteinemia as a risk factor for venous thromboembolic disease. Arch Intern Med 158 (1998) 2101-2106
10. Bousser M.G. Cerebral venous thrombosis: diagnosis and management. J Neurol 247 (2000) 252-258
11. Mantel N., and Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22 (1959) 719-748
12. In www.cochrane.org.
13. Hillier C.E.M., Collins P.W., Bowen D.J., Bowley S., and Wiles C.M. Inherited prothrombotic risk factors and cerebral venous thrombosis. QJM Int J Med 91 (1998) 677-680
14. Bugnicourt J.M., Roussel B., Tramier B., Lamy C., and Godefroy O. Cerebral Venous thrombosis and plasma concentration of Factor VIII and von Willebrand factor: a case control study. J Neurol Neurosurg Psychiatry 78 (2007) 699-701
15. Madonna P., Valentino S., Coppola A., Albisinni R., and Cerbone A.M. G20210A PRTH gene mutation and other trombophilic polymorphisms in patients with cerebral vein thrombosis. Stroke 31 (2000) 1785-1790
16. Voetsch B., Jin R.C., Bierl C., Deus-Silva L., Camargo E.C.S., Annichino-Bizacchi J.M., et al. Role of promotor polymorphisms in the plasma glutathione peroxidase (GPx-3) as a risk factor for cerebral venous thrombosis. Stroke 39 (2008) 303-307
17. Cantu C., Alonso E., Jara A., Martinez L., Rios C., Fernandez M.L., et al. Hyperhomocysteinemia, low folate and vitamin B12 concentrations, and methylene tetrahydrofolate reductase mutation in cerebral venous thrombosis. Stroke 35 (2004) 1790-1794
18. Boncoraglio G., Carriero M.R., Chiapparini L., Ciceri E., Ciusani E., Erbetta A., et al. Hyperhomocysteinemia and other thrombofilic risk factors in 26 patients with cerebral venous thrombosis. Eur J Neurol 11 (2004) 405-409
19. Gadelha T., Andre C., Juca A.A.V., and Nucci M. Prothrombin 20210A and oral contraceptive use as risk factors for cerebral venous thrombosis. Cerebrovasc Dis 9 (2005) 49-52
20. Dindagur N., Kruthika T.P., and Christopher R. Thrombofilic gene polymorphisms in puerperal cerebral veno-sinuses thrombosis. J Neurol Sci 249 (2006) 25-30
21. Ventura P., Cobelli M., Marietta M., Panini R., Rosa M.A., and Salvioli G. Hyperhomocysteinemia and other newly recognized inherited coagulation disorders (factor V Leiden and prothrombin gene mutation) in patients with idiopathic cerebral vein thrombosis. Cerebrovasc Dis 17 (2004) 153-159
22. Martinelli I., Battaglioli T., Pedotti P., Cattaneo M., and Mannucci P.M. Hyperhomocysteinemia in cerebral vein thrombosis. Blood 102 (2003) 1363-1366
23. Romero A., Marco P., Verdú J., Sánchez S., and Castaño. Trombofilia genética y trombois de senos venosos cerebrales. Med Clin (Barc) 128 17 (2007) 655-656
24. Den Heijer, Lewington S., and Clarke R. Homocysteine, MTHFR and risk of venous thrombosis: a meta-analysis of published epidemiological studies. J Thromb Haemostasis 3 (2005) 292-299
25. Chambers J.C., Ireland H., Thompson E., Reilly P., Obeid O.A., Refsum H., et al. Methylenetetrahydrofolate reductase 677 C→T mutation and coronary heart disease risk in UK Indian Asians. Arterioscler Thromb Vasc Biol 20 (2000) 2448-2452
26. Herrmann W., Schorr H., Obeid R., and Geisel J. Vitamin B-12 status, particularly holotranscobalamin II and methylmalonic acid concentrations, and hyperhomocysteinemia in vegetarians. Am J Clin Nutr 78 (2003) 131-136
27. Frosst P., Blom H.J., Micol R., Goyette P., Sheppard C.A., Mathews R.G., et al. A candidate genetic risk factor for vascular disease. A common mutation in methylene tetrahyfolate redutase. Nat Genet 10 (1995) 111-113
28. Ma J., Stampfer M.J., Hennekens C.H., Frosst P., Selhub J., Horsford J., et al. Methylenetetrahydrofolate reductase polymorphism, plasma folate, homocysteine, and risk of myocardial infarction in US physicians. Circulation 94 (1996) 2410-2416
29. Verhoef P., Kok F.J., Kluijtmans L.A., Blom H.J., Refsum H., Ueland P.M., et al. The 677C→T mutation in the methylenetetrahydrofolate reductase gene: associations with plasma total homocysteine levels and risk of coronary atherosclerotic disease. Atherosclerosis 132 (1997) 105-113
30. Wysokinska E.M., Wysokinski W.E., Brown R.D., Karnicki K., Gosk-Beirska I., Grill D., et al. Thrombophilia differences in cerebral venous sinus and lower extremity deep venous thrombosis. Neurology 70 (Feb 2008) 627-633